tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

HK:6160 Stock Latest News

BeOne Medicines price target raised to $412 from $400 at Truist
The FlyBeOne Medicines price target raised to $412 from $400 at Truist
6h ago
ONC
BeOne Medicines price target raised to $425 from $417 at RBC Capital
PremiumThe Fly
BeOne Medicines price target raised to $425 from $417 at RBC Capital
8h ago
ONC
BeOne Medicines Gains Clean Swiss Audit in Voluntary Disclosure
PremiumCompany Announcements
BeOne Medicines Gains Clean Swiss Audit in Voluntary Disclosure
9h ago
6160
BeOne Medicines price target raised to $410 from $400 at Guggenheim
PremiumThe Fly
BeOne Medicines price target raised to $410 from $400 at Guggenheim
10h ago
ONC
BeOne Medicines price target raised to $405 from $394 at Barclays
PremiumThe Fly
BeOne Medicines price target raised to $405 from $394 at Barclays
13h ago
ONC
BeOne Medicines Files 2025 Form 10-K, Underscoring Cross-Border Compliance
PremiumCompany AnnouncementsBeOne Medicines Files 2025 Form 10-K, Underscoring Cross-Border Compliance
1d ago
6160
BeOne Medicines posts 2025 results and issues cautious 2026 outlook
Premium
Company Announcements
BeOne Medicines posts 2025 results and issues cautious 2026 outlook
1d ago
6160
BeOne Medicines reports Q4 adjusted EPS $1.95, consensus $1.30
Premium
The Fly
BeOne Medicines reports Q4 adjusted EPS $1.95, consensus $1.30
1d ago
ONC
BeOne Medicines sees 2026 revenue $6.2B-$6.4B, consensus $6.44B
PremiumThe Fly
BeOne Medicines sees 2026 revenue $6.2B-$6.4B, consensus $6.44B
1d ago
ONC
BeOne Medicines Sets Date for 2025 Results and Dual-Regime Reporting
PremiumCompany Announcements
BeOne Medicines Sets Date for 2025 Results and Dual-Regime Reporting
16d ago
6160
BeOne Medicines price target raised to $394 from $385 at Barclays
PremiumThe Fly
BeOne Medicines price target raised to $394 from $385 at Barclays
24d ago
ONC
BeOne Medicines Grants New RSUs to 246 Employees Under Incentive Plan
PremiumCompany Announcements
BeOne Medicines Grants New RSUs to 246 Employees Under Incentive Plan
29d ago
6160
BeOne Medicines upgraded to Outperform from Market Perform at Bernstein
PremiumThe FlyBeOne Medicines upgraded to Outperform from Market Perform at Bernstein
2M ago
ONC
BeOne Medicines price target raised to $405 from $390 at Morgan Stanley
Premium
The Fly
BeOne Medicines price target raised to $405 from $390 at Morgan Stanley
2M ago
ONC
BeOne Medicines Grants 53,322 RSUs Under Incentive Plan to 155 Recipients
Premium
Company Announcements
BeOne Medicines Grants 53,322 RSUs Under Incentive Plan to 155 Recipients
2M ago
6160
BeOne Medicines says HERIZON-GEA-01 met dual primary endpoint of PFS
PremiumThe Fly
BeOne Medicines says HERIZON-GEA-01 met dual primary endpoint of PFS
2M ago
ONC
JAZZ
Zymeworks touts ‘unprecedented’ results from HERIZON-GEA-01 trial
PremiumThe Fly
Zymeworks touts ‘unprecedented’ results from HERIZON-GEA-01 trial
2M ago
ONC
JAZZ
Jazz reports efficacy, safety results from Phase 3 HERIZON-GEA-01 trial
PremiumThe Fly
Jazz reports efficacy, safety results from Phase 3 HERIZON-GEA-01 trial
2M ago
ONC
JAZZ
BeOne Medicines says HERIZON-GEA-01 met dual primary endpoint
PremiumThe Fly
BeOne Medicines says HERIZON-GEA-01 met dual primary endpoint
2M ago
ONC
BeOne Medicines granted FDA Fast Track Designation for carcinoma candidate
PremiumThe FlyBeOne Medicines granted FDA Fast Track Designation for carcinoma candidate
2M ago
ONC
Nurix Therapeutics price target raised to $30 from $24 at Mizuho
Premium
The Fly
Nurix Therapeutics price target raised to $30 from $24 at Mizuho
3M ago
ONC
NRIX
BeOne Medicines announces new data on sonrotoclax
Premium
The Fly
BeOne Medicines announces new data on sonrotoclax
3M ago
ONC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >